$ANVI
ANVI GLOBAL HOLDINGS, INC.

2023 Q3 Form 10-Q Financial Statement

#000107997323001083 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $59.24K
YoY Change 10.92%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $52.37K $53.68K $59.24K
YoY Change -14.51% -9.39% 10.92%
Operating Profit -$52.37K -$53.68K -$59.24K
YoY Change -14.51% -9.39% 10.92%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $14.05K
YoY Change
Pretax Income -$52.37K -$39.63K -$59.24K
YoY Change -14.51% -33.11% 10.92%
Income Tax
% Of Pretax Income
Net Earnings -$52.37K -$39.63K -$59.24K
YoY Change -14.51% -33.11% 10.92%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 120.0M shares 120.0M shares 120.0M shares
Diluted Shares Outstanding 120.0M shares 120.0M shares 120.0M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.740K
YoY Change 18.5%
Cash & Equivalents $219.00 $298.00 $4.741K
Short-Term Investments
Other Short-Term Assets $11.60K
YoY Change 2.29%
Inventory
Prepaid Expenses $5.000K $8.750K $11.60K
Receivables
Other Receivables
Total Short-Term Assets $5.219K $9.048K $16.34K
YoY Change -13.72% -44.61% 6.49%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $5.219K $9.048K $16.34K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $5.219K $9.048K $16.34K
YoY Change -13.72% -44.61% 6.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.96K $27.53K $42.60K
YoY Change -29.38% -35.38% -70.65%
Accrued Expenses $900.0K $900.0K $900.0K
YoY Change 0.0% 0.0% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.872M $1.824M $1.619M
YoY Change 12.11% 12.64% 17.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.872M $1.824M $1.619M
Total Long-Term Liabilities $0.00
Total Liabilities $1.872M $1.824M $1.619M
YoY Change 12.11% 12.64% 17.26%
SHAREHOLDERS EQUITY
Retained Earnings -$1.925M -$1.873M -$1.661M
YoY Change 11.79% 12.76%
Common Stock $58.50K $58.50K $58.50K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.867M -$1.814M -$1.603M
YoY Change
Total Liabilities & Shareholders Equity $5.219K $9.048K $16.34K
YoY Change -13.72% -44.61% 6.49%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$52.37K -$39.63K -$59.24K
YoY Change -14.51% -33.11% 10.92%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$21.25K -$22.65K
YoY Change -6.16% 61.05%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $19.99K $20.50K
YoY Change -2.51% 46.43%
NET CHANGE
Cash From Operating Activities -$21.25K -$22.65K
Cash From Investing Activities
Cash From Financing Activities $19.99K $20.50K
Net Change In Cash -$1.269K -$2.150K
YoY Change -40.98% 3259.38%
FREE CASH FLOW
Cash From Operating Activities -$21.25K -$22.65K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001570132
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q2 ANVI Gain From Settlement Of Accounts Payable
GainFromSettlementOfAccountsPayable
usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2022Q2 ANVI Gain From Settlement Of Accounts Payable
GainFromSettlementOfAccountsPayable
usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-05-31
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
333-188648
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
ANVI GLOBAL HOLDINGS, INC.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-1226144
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
1135 Kildaire Farm Road
CY2023Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 319-4
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Cary
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27511
CY2023Q2 dei City Area Code
CityAreaCode
(408)
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
821-4491
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
119950000 shares
CY2023Q2 us-gaap Cash
Cash
298 usd
CY2023Q1 us-gaap Cash
Cash
1567 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8750 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12500 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
9048 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
14067 usd
CY2023Q2 us-gaap Assets
Assets
9048 usd
CY2023Q1 us-gaap Assets
Assets
14067 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
27527 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
48904 usd
CY2023Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
396000 usd
CY2023Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
360000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
900000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
900000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
500005 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
480020 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1823532 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1788924 usd
CY2023Q2 us-gaap Liabilities
Liabilities
1823532 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1788924 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
119950000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119950000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
119950000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119950000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
119950 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
119950 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
-61450 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
-61450 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1872984 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1833357 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1814484 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1774857 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9048 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14067 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
53678 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
59238 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
53678 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
59238 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-53678 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-59238 usd
CY2023Q2 ANVI Gain From Settlement Of Accounts Payable
GainFromSettlementOfAccountsPayable
14051 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14051 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39627 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59238 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-39627 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-59238 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119950000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119950000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119950000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119950000 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1543354 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-59238 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1602592 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1774857 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-39627 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1814484 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-39627 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-59238 usd
CY2023Q2 ANVI Gain From Settlement Of Accounts Payable
GainFromSettlementOfAccountsPayable
14051 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3750 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-255 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7326 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
333 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
36000 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
36000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21254 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22650 usd
CY2023Q2 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
19985 usd
CY2022Q2 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
20500 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19985 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20500 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1269 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2150 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1567 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6891 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
298 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4741 usd
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zh91djqVNLE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_868_zEf7bV1SIWC">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Significant estimates include the estimated useful lives of property and equipment.  Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p>
CY2023Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zWhQ8LpfaHWc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_864_zvePOIZsBbGc">Concentrations of Credit Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p>
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1872984 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8750 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12500 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
900000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
900000 usd
CY2023Q2 ANVI Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
396000 usd
CY2023Q1 ANVI Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
360000 usd
CY2023Q2 ANVI Due To Officers Or Stockholder Current
DueToOfficersOrStockholderCurrent
500005 usd
CY2023Q1 ANVI Due To Officers Or Stockholder Current
DueToOfficersOrStockholderCurrent
480020 usd

Files In Submission

Name View Source Status
0001079973-23-001083-index-headers.html Edgar Link pending
0001079973-23-001083-index.html Edgar Link pending
0001079973-23-001083.txt Edgar Link pending
0001079973-23-001083-xbrl.zip Edgar Link pending
anvi-20230331.xsd Edgar Link pending
anvi-20230331_cal.xml Edgar Link unprocessable
anvi-20230331_def.xml Edgar Link unprocessable
anvi-20230331_lab.xml Edgar Link unprocessable
anvi_10q.htm Edgar Link pending
anvi_ex31z1.htm Edgar Link pending
anvi_ex32z1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
anvi_10q_htm.xml Edgar Link completed
anvi-20230331_pre.xml Edgar Link unprocessable